Unlock stock picks and a broker-level newsfeed that powers Wall Street.

IOB - Delayed Quote CHF

Roche Holding AG (0QOK.IL)

261.50
+3.05
+(1.18%)
As of April 24 at 5:34:01 PM GMT+1. Market Open.
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
62,395,000
62,395,000
60,441,000
65,814,000
62,801,000
Cost of Revenue
16,283,000
16,283,000
16,357,000
19,737,000
19,647,000
Gross Profit
46,112,000
46,112,000
44,084,000
46,077,000
43,154,000
Operating Expense
32,695,000
32,695,000
28,689,000
28,601,000
24,999,000
Operating Income
13,417,000
13,417,000
15,395,000
17,476,000
18,155,000
Net Non Operating Interest Income Expense
-1,151,000
-1,151,000
-814,000
-673,000
-414,000
Pretax Income
11,793,000
11,793,000
14,079,000
16,327,000
17,398,000
Tax Provision
2,606,000
2,606,000
1,721,000
2,796,000
2,463,000
Net Income Common Stockholders
8,277,000
8,277,000
11,498,000
12,421,000
13,930,000
Average Dilution Earnings
--
--
--
-1,000
-1,000
Diluted NI Available to Com Stockholders
8,277,000
8,277,000
11,498,000
12,420,000
13,929,000
Basic EPS
10.39
--
14.40
15.52
16.38
Diluted EPS
10.31
--
14.31
15.37
16.20
Basic Average Shares
797,000
--
799,000
800,000
850,000
Diluted Average Shares
802,000
--
804,000
808,000
860,000
Total Operating Income as Reported
13,417,000
13,417,000
15,395,000
17,476,000
18,155,000
Total Expenses
48,978,000
48,978,000
45,046,000
48,338,000
44,646,000
Net Income from Continuing & Discontinued Operation
8,277,000
8,277,000
11,498,000
12,421,000
13,930,000
Normalized Income
8,360,353
8,360,353
11,600,726
12,972,285
14,446,516
Interest Income
260,000
260,000
195,000
67,000
--
Interest Expense
1,403,000
1,403,000
997,000
690,000
419,000
Net Interest Income
-1,151,000
-1,151,000
-814,000
-673,000
-414,000
EBIT
13,196,000
13,196,000
15,076,000
17,017,000
17,817,000
EBITDA
16,619,000
16,619,000
18,540,000
20,861,000
22,260,000
Reconciled Cost of Revenue
16,283,000
16,283,000
16,357,000
19,737,000
19,647,000
Reconciled Depreciation
3,423,000
3,423,000
3,464,000
3,844,000
4,443,000
Net Income from Continuing Operation Net Minority Interest
8,277,000
8,277,000
11,498,000
12,421,000
13,930,000
Total Unusual Items Excluding Goodwill
-107,000
-107,000
-117,000
-665,000
-602,000
Total Unusual Items
-107,000
-107,000
-117,000
-665,000
-602,000
Normalized EBITDA
16,726,000
16,726,000
18,657,000
21,526,000
22,862,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-23,647
-23,647
-14,274
-113,715
-85,484
12/31/2021 - 3/6/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NOV.HA Novo Nordisk A/S
55.30
+0.44%
 
NOV.F Novo Nordisk A/S
55.30
+0.36%
 
LLY.DE Eli Lilly and Company
746.80
+3.19%
 
NOVN.SW Novartis AG
92.00
+1.21%
 
NONOF Novo Nordisk A/S
61.55
-3.15%
 
NOV.DE Novo Nordisk A/S
54.96
+1.33%
 
JNJ Johnson & Johnson
154.93
-0.29%
 
AMGN Amgen Inc.
279.84
+0.70%
 
MRK Merck & Co., Inc.
79.84
+1.40%
 
ABBV AbbVie Inc.
180.37
+1.88%